Slow rehabilitation of drug-coated stents
Slow rehabilitation of drug-coated stents
New research supports the safety of drug-coated stents, but they aren't for everyone.
It's been a tough time for drug-coated stents. After being hailed as a revolutionary new therapy, these tiny wire cages fell from grace, tarnished by reports that they are responsible for a small number of heart attacks and deaths a year or more after implantation.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.